130 results
Page 5 of 7
424B5
czsqt4c
10 Sep 19
Prospectus supplement for primary offering
4:09pm
6-K
EX-99.2
84prmx bor
4 Sep 19
Current report (foreign)
7:04am
6-K
EX-99.1
xkktc169
4 Sep 19
Current report (foreign)
7:04am
6-K
EX-99.1
y13hk
23 Aug 19
Celyad Reports Half Year 2019 Financial Results and Second Quarter Business Highlights
7:53am
6-K
EX-99.2
ti08fqnclabu5zou
23 Aug 19
Celyad Reports Half Year 2019 Financial Results and Second Quarter Business Highlights
7:53am
6-K
EX-99.1
ygiw ytdri8a3bes
9 Jul 19
Current report (foreign)
6:20am
6-K
EX-99.1
whsf7xau
8 Jul 19
Current report (foreign)
7:22am
6-K
EX-99.1
unbatw7k1f4wu vhpxg
8 Jul 19
Celyad to Host Conference Call to Review Clinical
7:19am
6-K
EX-99.1
icas6
3 Jul 19
Celyad Announces Strategic Updates to the Autologous r/r AML and MDS Program
6:22am
6-K
EX-99.1
sqnsbh0o9p0qg dajlu
15 May 19
Celyad Announces First Quarter 2019 and Recent Business Highlights
7:00am
6-K
EX-99.1
wcsj62ye7wd
3 Apr 19
Celyad Appoints Filippo Petti as Chief Executive Officer
4:40pm
6-K
EX-99.2
jde74vp
3 Apr 19
Celyad Appoints Filippo Petti as Chief Executive Officer
4:40pm
6-K
EX-99.1
8jfp5 h1bh3bn7yyy5v
21 Mar 19
Celyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of
12:56pm
6-K
EX-99.1
bzslwej27jfl
11 Mar 19
Celyad Appoints Anne Moore as Vice President
6:07am
6-K
EX-99.1
gap9cmd7yy wlh
7 Jan 19
Current report (foreign)
7:11am
6-K
EX-99.2
smg91lw
7 Jan 19
Current report (foreign)
7:11am
6-K
EX-99.1
jgq0pkf9sk fdw8e2ab4
4 Dec 18
Celyad Presents Update onCYAD-01
1:48pm